Scarica l'app Stockscreener
9.94
2.07%
-0.21
Dopo l'orario di chiusura:
9.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$10.15
Aprire:
$10.04
Volume 24 ore:
1.49M
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.58B
Reddito:
$93.95M
Utile/perdita netta:
$-129.87M
Rapporto P/E:
-11.04
EPS:
-0.9
Flusso di cassa netto:
$-202.88M
1 W Prestazione:
+2.05%
1M Prestazione:
+18.33%
6M Prestazione:
-4.05%
1 anno Prestazione:
+73.17%
Intervallo 1D:
$9.83
$10.16
Intervallo di 1 settimana:
$9.26
$10.57
Portata 52W:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Confronta WVE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
9.94 | 1.55B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-04 | Iniziato | Canaccord Genuity | Buy |
| 2025-07-28 | Iniziato | Oppenheimer | Outperform |
| 2025-07-16 | Iniziato | Citigroup | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Wedbush | Outperform |
| 2025-02-25 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Ripresa | JP Morgan | Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-09-09 | Iniziato | JP Morgan | Overweight |
| 2024-05-15 | Iniziato | Wells Fargo | Overweight |
| 2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Raymond James | Outperform |
| 2023-05-24 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-15 | Ripresa | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Iniziato | Guggenheim | Buy |
| 2019-07-15 | Iniziato | Cowen | Market Perform |
| 2019-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-08-07 | Iniziato | Stifel | Buy |
| 2018-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2017-02-15 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-07 | Iniziato | Jefferies | Buy |
| 2015-12-07 | Iniziato | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences is a new Buy at Canaccord Genuity on near-term catalysts - MSN
Tan Aik Na sells Wave Life Sciences (WVE) shares for $194k - Investing.com Nigeria
Wave Life Sciences gains as JPMorgan suspends rating (update) - MSN
Applying big data sentiment scoring on Wave Life Sciences Ltd.Trade Risk Report & Community Consensus Stock Picks - Newser
Risk adjusted return profile for Wave Life Sciences Ltd. analyzedMarket Rally & Community Verified Watchlist Alerts - Newser
Wave Life Sciences gains as JPMorgan suspends rating (update) (WVE:NASDAQ) - Seeking Alpha
Wave Life Sciences Ltd. shares rise 2.69% intraday after Ocean Power Technologies, Inc. highlights marine energy innovations. - AInvest
Pattern Scan Adds Wave Life Sciences Ltd. to WatchlistTrade Ideas & Safe Entry Momentum Tips - newsimpact.co.kr
Wave Life Sciences Ltd. Recovery Linked to Earnings SurpriseJuly 2025 Highlights & High Accuracy Trade Signal Alerts - newsyoung.net
Wave Life Sciences director Henry sells $85k in shares By Investing.com - Investing.com Nigeria
Wave Life Sciences director Henry sells $85k in shares - Investing.com
Wave Life Sciences Shareholders Approve Key Proposals - MSN
Will Weaker Sales and Deeper Losses Shift Wave Life Sciences' (WVE) Investment Narrative? - simplywall.st
Is Wave Life Sciences Ltd. the Top Chart Pick This WeekAI Based High Gain Watchlist Scanner Shared - beatles.ru
Wave Life Sciences Director Sells 1,127 Shares for $8.75 Each. - AInvest
Oppenheimer Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $24 - 富途牛牛
CCORF Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $19 - 富途牛牛
Wave Life Sciences Highlights RNA Platform Advancements - TipRanks
A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $18 to $24 - 富途牛牛
Wave Life Sciences stock a new Buy at Canaccord Genuity (WVE) - Seeking Alpha
Wave Life Sciences stock initiated with Buy rating by Canaccord - Investing.com Australia
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wave Life Sciences Ltd. shares rise 6.03% premarket after OraSure Technologies appoints new Chief Commercial Officer. - AInvest
Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Trimmed Their Revenue Forecasts By 13% - simplywall.st
Wave Life Sciences signals key Q3 and Q4 data catalysts as INHBE and AATD programs advance - MSN
When is Wave Life Sciences Ltd. stock expected to show significant growthSuperior stock growth - Jammu Links News
What analysts say about Wave Life Sciences Ltd. stockConsistent triple-digit returns - Jammu Links News
Earnings Update: Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported And Analysts Are Trimming Their Forecasts - 富途牛牛
How many analysts rate Wave Life Sciences Ltd. as a “Buy”Triple-digit wealth increases - Jammu Links News
What are analysts’ price targets for Wave Life Sciences Ltd. in the next 12 monthsUnlock powerful trading strategies for gains - Jammu Links News
What is Wave Life Sciences Ltd. company’s growth strategyDiscover undervalued stocks ready to soar - Jammu Links News
Is Wave Life Sciences Ltd. a growth stock or a value stockExceptional profit potential - Jammu Links News
What are the latest earnings results for Wave Life Sciences Ltd.Capitalize on emerging market sectors - Jammu Links News
How does Wave Life Sciences Ltd. compare to its industry peersBuild a portfolio that withstands market volatility - Jammu Links News
Insights Into WAVE Life Sciences's Upcoming Earnings - 富途牛牛
How strong is Wave Life Sciences Ltd. company’s balance sheetSmart Portfolio Outlook For Consistent Profits - Jammu Links News
Why is Wave Life Sciences Ltd. stock attracting strong analyst attentionPost Market Updates For Consistent Profits - Jammu Links News
Wave Life Sciences Ltd. shares rise 2.72% intraday after TELUS CORPORATION's ESG initiatives and new product focus. - AInvest
WAVE Life Sciences Reports Q2 2025 Earnings: RNA Editing Progress Amid Revenue Decline and Strong Cash Position - AInvest
Wave Life Sciences Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2025 Earnings Call Transcript - Insider Monkey
Need To Know: The Consensus Just Cut Its Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates For 2025 - Yahoo Finance
Wave Life Sciences Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):